Oral Drug Therapy of Male Sexual Dysfunction: A Guide to Clinical Management extensively reviews the physiology and pharmacology of male sexual dysfunction. In addition, it outlines current pharmacologic strategies in the management of erectile dysfunction as well as rapid ejaculation, and previews the next generation of phosphodiesterase inhibitors that are now pending final FDA review. Other areas of interest include the special risk factors that lead to ED and often impede or complicate its treatment, and the distinguishing of facts versus marketing of nutrition supplements in the management of ED.